Population
2 patients with familial hypertrophic cardiomyopathy
Design
Case_series
Authors
Loading...
Variable mutant beta-MHC fractions in HCM cases should not change practice; leaves open systematic quantification across mutations.
The study demonstrates significant variability in the ratio of mutant to wildtype myosin heavy chain in patients with familial hypertrophic cardiomyopathy, highlighting the need to quantify this ratio for functional studies.
Nier et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: